Comparative effects of ticrynafen and hydrochlorothiazide on blood pressure, renal function, serum uric acid and electrolytes, and body fluid spaces in hypertensive man.

Author: BauerJ H, BrooksC S

Paper Details 
Original Abstract of the Article :
25 hypertensive subjects underwent a double-blind, randomized study to compare the effects of ticrynafen (TCNF) with hydrochlorothiazide (HCTZ) on blood pressure (BP), renal function, serum uric acid (UA) and electrolytes, and body fluid spaces. BP was similarly lowered by TCNF and HCTZ. Neither TCN...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1159/000181670

データ提供:米国国立医学図書館(NLM)

Ticrynafen vs. Hydrochlorothiazide: A Comparative Study

The desert of [hypertension] is a treacherous landscape, requiring careful navigation to manage this prevalent condition. This study delves into the comparative effects of two diuretics, [ticrynafen] and [hydrochlorothiazide], on blood pressure, renal function, and other relevant parameters.

A Double-Blind, Randomized Study: Comparing Diuretic Effects

The researchers conducted a double-blind, randomized study to compare the efficacy and side effects of ticrynafen and hydrochlorothiazide in a group of hypertensive individuals.

Navigating the Desert of Hypertension Treatment

This study provides valuable insights into the effects of two commonly used diuretics in the management of hypertension. The findings highlight the potential advantages and disadvantages of each drug, offering guidance for clinicians in selecting appropriate treatment options.

Dr.Camel's Conclusion

In the desert of hypertension, we must carefully select our tools to effectively combat this formidable foe. This study provides a valuable comparison of two diuretics, ticrynafen and hydrochlorothiazide, offering a roadmap for clinicians in navigating the diverse treatment options available. As we continue our quest for optimal hypertension management, it is crucial to remain informed about the latest research and the potential benefits and risks of various therapeutic approaches.
Date :
  1. Date Completed 1979-10-24
  2. Date Revised 2018-02-15
Further Info :

Pubmed ID

471153

DOI: Digital Object Identifier

10.1159/000181670

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.